Cita APA

Do Pazo Oubiña, F., del Rosario García, B., Miarons, M., Legido Perdices, E. M., Prado Mel, E., Díaz, R. R., & Gutiérrez Nicolás, F. (2026). Impact of UGT1A1*28 Allele on the Safety and Effectiveness of Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer: Real-World Evidence.

Citación estilo Chicago

Do Pazo Oubiña, Fernando, Betel del Rosario García, Marta Miarons, Eva M. Legido Perdices, Elena Prado Mel, Ruth Ramos Díaz, y Fernando Gutiérrez Nicolás. Impact of UGT1A1*28 Allele On the Safety and Effectiveness of Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer: Real-World Evidence. 2026.

Cita MLA

Do Pazo Oubiña, Fernando, et al. Impact of UGT1A1*28 Allele On the Safety and Effectiveness of Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer: Real-World Evidence. 2026.